Condition (MeSH)
Muscular Dystrophy, Emery-Dreifuss
ClinicalTrials.gov lists 6 trials for Muscular Dystrophy, Emery-Dreifuss or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 6 trials are tagged with Muscular Dystrophy, Emery-Dreifuss itself; the rest are tagged with a narrower condition beneath it.
When did Muscular Dystrophy, Emery-Dreifuss trials start? (6)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2022 | 1 |
| 2021 | 1 |
| 2016 | 1 |
| 2013 | 1 |
| 2009 | 1 |
| 2004 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Muscular Dystrophy, Emery-Dreifuss trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 2 |
| Observational | 4 |
How many Muscular Dystrophy, Emery-Dreifuss trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 3 |
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Muscular Dystrophy, Emery-Dreifuss trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
| Vastra Gotaland Region | 1 |
Which publications cover Muscular Dystrophy, Emery-Dreifuss? (5)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Modifier locus of the skeletal muscle involvement in Emery-Dreifuss muscular dystrophy. | Human genetics | 2011 | Yes |
| Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy. | The Journal of cell biology | 2014 | No |
| Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. | Circulation. Cardiovascular imaging | 2011 | No |
| Muscle MRI in inherited neuromuscular disorders: past, present, and future. | Journal of magnetic resonance imaging : JMRI | 2007 | No |
| The muscular dystrophies. | Lancet (London, England) | 2002 | No |
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Emery-Dreifuss muscular dystrophy | Point prevalence | 1-9 / 1 000 000 | Europe | Not stated | Unspecified |
| Emery-Dreifuss muscular dystrophy | Point prevalence | 1-9 / 1 000 000 | Europe | Not stated | Exact |
| Emery-Dreifuss muscular dystrophy | Point prevalence | 1-9 / 1 000 000 | Europe | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Emery-Dreifuss muscular dystrophy | 261 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Emery-Dreifuss muscular dystrophy | 261 | Exact | Orphadata Science knowledge files, Product 1 |
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials.
Not computed for conditions with fewer than 10 trials: drugs tested.